TTrialPathMatch Me to Trials
← Back to trials
RecruitingSpinal Cord Injuries

Evaluation of New MRI Sequences Including 3D-FGAPSIR for the Optimization of Inflammatory Spinal Cord Lesions Research

Eligible age

18+ yrs

Accepts

All genders

Locations

0 states

Healthy volunteers

No

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

* verification of inclusion and non-inclusion criteria * information and collection of consent * standard imaging protocol prescribed as part of the usual treatment: sagittal T1 and T2 slices after injection of contrast product (Gadolinium), 3D STIR and 3D PSIR sequence. * 3D FGAPSIR sequence at the level of the cervical cord for the duration of the additional sequence is 10 minutes, for a total examination time of 40 minutes (instead of 30 minutes)

Sponsor: Fondation Ophtalmologique Adolphe de Rothschild

You may qualify if…

  • ✓ Patient over 18 years old
  • ✓ To benefit from a medullary exploration planned by 3T MRI as part of a first evaluation or a reassessment of inflammatory involvement of the nevrax
  • ✓ Express consent to participate in the study
  • ✓ Affiliate or beneficiary of a social security scheme

You may not qualify if…

  • ✕ Patient benefiting from a legal protection measure
  • ✕ Pregnant, parturient or breastfeeding woman
  • ✕ Absolute or relative contraindication to MRI

Source: ClinicalTrials.gov · NCT04906928 · last updated 2026-01-05